Literature DB >> 4051595

Negative anticardiolipin antibodies and vascular complications in Behçet's syndrome.

J Efthimiou, E N Harris, G R Hughes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4051595      PMCID： PMC1001754          DOI： 10.1136/ard.44.10.725

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  1 in total

Review 1.  Behçet's disease. Report of 41 cases and a review of the literature.

Authors:  T Chajek; M Fainaru
Journal:  Medicine (Baltimore)       Date:  1975-05       Impact factor: 1.889
  1 in total
  5 in total

Review 1.  Anticardiolipin (aCL) antibodies in a patient with Behçet's syndrome with vena cava inferior thrombosis.

Authors:  D G Ebo; P G Bracke; L S De Clerck; L M Francx; W J Stevens
Journal:  Clin Rheumatol       Date:  1997-01       Impact factor: 2.980

2.  Absence of antiphospholipid antibodies in Behçet's disease.

Authors:  M Karmochkine; M C Boffa; B Wechsler; J C Piette; P Godeau
Journal:  Ann Rheum Dis       Date:  1993-08       Impact factor: 19.103

Review 3.  Thromboembolic disease in vasculitis.

Authors:  Gunnar Tomasson; Paul A Monach; Peter A Merkel
Journal:  Curr Opin Rheumatol       Date:  2009-01       Impact factor: 5.006

4.  Association of anti-cardiolipin antibodies with vascular thrombosis and neurological manifestation of Behçets disease.

Authors:  A N al-Dalaan; S R al-Ballaa; M A al-Janadi; S Bohlega; S Bahabri
Journal:  Clin Rheumatol       Date:  1993-03       Impact factor: 2.980

5.  Anticardiolipin antibodies in Behçet's syndrome: a predictor of a more severe disease.

Authors:  R M Pereira; C R Gonçalves; C Bueno; E de S Meirelles; W Cossermelli; R M de Oliveira
Journal:  Clin Rheumatol       Date:  1989-06       Impact factor: 2.980
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.